CDC

Biosafety in Microbiological and Biomedical Laboratories (BMBL), 6th Edition

CDC and NIH advisory guidance on biosafety practices and containment levels for laboratories working with infectious agents and toxins.

Clinical Laboratory Improvement Amendments (CLIA)

Federal quality standards for US laboratories testing human specimens, administered by CMS with CDC and FDA under 42 CFR Part 493.

Clinical Laboratory Improvement Amendments (CLIA) and Clinical Genetic Testing

CLIA sets federal quality standards for clinical laboratory testing on humans, including genetic tests; CMS runs the program with FDA and CDC.

Outbreak Investigation and Infection Control

Topic entry for outbreak investigation and infection control, pointing to CDC outbreak resources and related OSHA, CMS and state requirements.

Public Health Reporting and Surveillance

State-mandated reporting of notifiable diseases by providers and labs to health departments, which share case data with CDC through NNDSS.

U.S. National Pandemic Influenza Strategy and HHS Pandemic Influenza Plan

Federal pandemic influenza planning documents, including the National Strategy for Pandemic Influenza and the HHS Pandemic Influenza Plan, indexed by …